IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome

OBJECTIVE: The Guillain–Barré syndrome (GBS) is an acute, immune‐mediated disease of peripheral nerves. Plasmablasts and plasma cells play a central role in GBS by producing neurotoxic antibodies. The standard treatment for GBS is high‐dose intravenous immunoglobulins (IVIg), however the working mec...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Clin Transl Neurol
Asıl Yazarlar: Brem, Maarten D., Jacobs, Bart C., van Rijs, Wouter, Fokkink, Willem Jan R., Tio‐Gillen, Anne P., Walgaard, Christa, van Doorn, Pieter A., IJspeert, Hanna, van der Burg, Mirjam, Huizinga, Ruth
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6331722/
https://ncbi.nlm.nih.gov/pubmed/30656191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.687
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller